Neil Gross, Professor at MD Anderson Cancer Center, shared a post on X:
“Great to be in DC today NRG Oncology giving an update on the progress of HN014 C-PRE for patients with advanced, resectable skin CSCC cancer. >100 sites activated in the US alone and accrual.”
More posts featuring Skin Cancer.
